The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis

被引:234
作者
Blum, A. [1 ]
Shamburek, R. [2 ]
机构
[1] Technion Israel Inst Technol, Dept Med, Fac Med, Baruch Padeh Poria Med Ctr, IL-15208 Lower Galilee, Israel
[2] NHLBI, Translat Branch, NIH, Bethesda, MD 20892 USA
关键词
Endothelial function; Inflammation; Stein cells and statins; COA REDUCTASE INHIBITION; THERAPY; PRAVASTATIN; ATORVASTATIN; DYSFUNCTION; RESTENOSIS; PLAQUE;
D O I
10.1016/j.atherosclerosis.2008.08.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Statins have been demonstrated to significantly affect the prognosis and outcome of patients with risk factors to atherosclerosis (in primary and secondary prevention trials). Several clinical and recently basic studies have suggested an extra-beneficial effect of the statins in the prevention of atherosclerosis and coronary artery disease. These Studies showed that statins may affect the cardiovascular system beyond their effect on the lipid profile, and it was suggested that they affect the immunological system and vascular inflammation. Many of the beneficial pleiotropic effects of statins occur as a result of modulated endothelial function and reduced inflammatory processes. Attempting to understand these properties of statins is an exciting field of research that will also improve our understanding of vascular biology in health and disease, and thus enable the better use of this drug class in clinical practice. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:325 / 330
页数:6
相关论文
共 24 条
[1]   Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].
Albert, MA ;
Danielson, E ;
Rifai, N ;
Ridker, PM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70
[2]  
Cortellaro M, 2002, THROMB HAEMOSTASIS, V88, P41
[3]   HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells [J].
Dichtl, W ;
Dulak, J ;
Frick, M ;
Alber, HF ;
Schwarzacher, SP ;
Ares, MPS ;
Nilsson, J ;
Pachinger, O ;
Weidinger, F .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (01) :58-63
[4]   Effective strategies for long-term statin use [J].
Fonarow, GC ;
Watson, KE .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (1A) :27I-34I
[5]  
Gelosa P, 2007, VASC HEALTH RISK MAN, V3, P567
[6]   Inhibition of hydroxymethylglutaryl-coenzyme A reductase reduces Th1 development and promotes Th2 development [J].
Hakamada-Taguchi, R ;
Uehara, Y ;
Kuribayashi, K ;
Numabe, A ;
Saito, K ;
Negoro, H ;
Fujita, T ;
Toyo-oka, T ;
Kato, T .
CIRCULATION RESEARCH, 2003, 93 (10) :948-956
[7]   Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients [J].
Holm, T ;
Andreassen, AK ;
Ueland, T ;
Kjekshus, J ;
Froland, SS ;
Kjekshus, E ;
Simonsen, S ;
Aukrust, P ;
Gullestad, L .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (06) :815-+
[8]   Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) study [J].
Kinlay, S ;
Schwartz, GG ;
Olsson, AG ;
Rifai, N ;
Sasiela, WJ ;
Szarek, M ;
Ganz, P ;
Libby, P .
CIRCULATION, 2004, 110 (04) :386-391
[9]   HMG-CoA reductase inhibition improves anti-aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis [J].
Kuwahara, Noriko ;
Sasaki, Susumu ;
Kobara, Miyuki ;
Nakata, Tetsuo ;
Tatsumi, Tetsuya ;
Irie, Hidekazu ;
Narumiya, Hiromichi ;
Hatta, Tsuguru ;
Takeda, Kazuo ;
Matsubara, Hiroaki ;
Hushiki, Shinji .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 123 (02) :84-90
[10]   Statins as a newly recognized type of immunomodulator [J].
Kwak, B ;
Mulhaupt, F ;
Myit, S ;
Mach, F .
NATURE MEDICINE, 2000, 6 (12) :1399-1402